1. Brunzell J.D., Davidson M., Furberg C.D. et al. Lipoprotein
Management in Patients With Cardiometabolic Risk. Consensus
statement from the American Diabetes Association and the American
College of Cardiology Foundation. Diabetes Care 2008; 31: 811822.
2. Turner R.C., Millns H., Neil H.A. et al.: Risk factors for coronary artery
disease in noninsulin dependent diabetes mellitus: United Kingdom
prospective diabetes study (UKPDS: 23). BMJ 316: 823828, 1998.
3. Greenland P., Abrams J., Aurigemma G.P. et al., the Writing Group
III: Prevention Conference V: Beyond secondary prevention:
identifying the highrisk patient for primary prevention: noninvasive
tests of atherosclerotic burden. Circulation 101: E16E22, 2000.
4. Taylor A.J., Merz C.N., Udelson J.E.: 34th Bethesda Conference:
Executive summary – can atherosclerosis imaging techniques improve
the detection of patients at risk for ischemic heart disease? J Am Coll
Cardiol 41: 18601862, 2003.
5. National Cholesterol Education Program Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in Adults:
Executive summary of the Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection, Evaluation,
and Treatment of High Blood Cholesterol in Adults (Adult Treatment
Panel III). JAMA 285: 24862497, 2001.
6. American Diabetes Association: Standards of medical care in
diabetes – 2008. Diabetes Care 2008; 31 (Suppl. 1): S12S54.
7. Repas T.B. Think Beyond the Numbers, Don’t Forget the Patient.
JAOA 2008; 108 (5), Suppl. 3, 14.
8. Toth P.P. Subclinical atherosclerosis: what it is, what it means and
what we can do about it. International Journal of Clinical Practice
2008; 62 (
, 12461254.9. Williams K.J., Feig J.E., Fisher E.A. Rapid Regression of
Atherosclerosis: Insights From the Clinical and Experimental Literature.
Nature Clinical Practice Cardiovascular Medicine 2008; 5 (2): 91102.
????? ?????? ???? ?????????
Наверх страницы
